N29S (p.Asn29Ser) variant of TP53 (Cellular tumor antigen p53)

N29S (p.Asn29Ser) in TP53 (Cellular tumor antigen p53) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.41 / 1. The record also includes population frequency data, experimental measurements, and structural context.

N29S (p.Asn29Ser) variant details